134 related articles for article (PubMed ID: 9038738)
1. Histological features predictive of liver fibrosis in chronic hepatitis C infection.
Paradis V; Mathurin P; Laurent A; Charlotte F; Vidaud M; Poynard T; Hoang C; Opolon P; Bedossa P
J Clin Pathol; 1996 Dec; 49(12):998-1004. PubMed ID: 9038738
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model.
Wong VS; Wight DG; Palmer CR; Alexander GJ
J Clin Pathol; 1996 Jun; 49(6):465-9. PubMed ID: 8763259
[TBL] [Abstract][Full Text] [Related]
3. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta.
Kanzler S; Baumann M; Schirmacher P; Dries V; Bayer E; Gerken G; Dienes HP; Lohse AW
J Viral Hepat; 2001 Nov; 8(6):430-7. PubMed ID: 11703574
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease.
Roulot D; Durand H; Coste T; Rautureau J; Strosberg AD; Benarous R; Marullo S
Hepatology; 1995 Feb; 21(2):298-304. PubMed ID: 7843697
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.
Castilla A; Prieto J; Fausto N
N Engl J Med; 1991 Apr; 324(14):933-40. PubMed ID: 1900574
[TBL] [Abstract][Full Text] [Related]
6. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.
Roulot D; Sevcsik AM; Coste T; Strosberg AD; Marullo S
Hepatology; 1999 Jun; 29(6):1730-8. PubMed ID: 10347115
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of TGF-β1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection.
Tache D; Bogdan F; Pisoschi C; Baniţă M; Stănciulescu C; Fusaru AM; Comănescu V
Rom J Morphol Embryol; 2011; 52(1 Suppl):409-12. PubMed ID: 21424084
[TBL] [Abstract][Full Text] [Related]
8. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
Paradis V; Mathurin P; Kollinger M; Imbert-Bismut F; Charlotte F; Piton A; Opolon P; Holstege A; Poynard T; Bedossa P
J Clin Pathol; 1997 May; 50(5):401-6. PubMed ID: 9215123
[TBL] [Abstract][Full Text] [Related]
9. Cytokine gene expression in cirrhotic and non-cirrhotic human liver.
Llorent L; Richaud-Patin Y; Alcocer-Castillejos N; Ruiz-Soto R; Mercado MA; Orozco H; Gamboa-Domínguez A; Alcocer-Varela J
J Hepatol; 1996 May; 24(5):555-63. PubMed ID: 8773910
[TBL] [Abstract][Full Text] [Related]
10. Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.
Kumagai N; Kuramochi S; Toda K; Iwabuchi N; Tsuchimoto K; Tsunematsu S; Saito H; Morizane T; Tsuchiya M; Ishii H
J Gastroenterol; 1996 Feb; 31(1):69-74. PubMed ID: 8808431
[TBL] [Abstract][Full Text] [Related]
11. TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.
Argentou N; Germanidis G; Hytiroglou P; Apostolou E; Vassiliadis T; Patsiaoura K; Sideras P; Germenis AE; Speletas M
Inflamm Res; 2016 May; 65(5):355-65. PubMed ID: 26856334
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies.
Spee B; Arends B; van den Ingh TS; Brinkhof B; Nederbragt H; Ijzer J; Roskams T; Penning LC; Rothuizen J
Liver Int; 2006 Aug; 26(6):716-25. PubMed ID: 16842329
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the intrahepatic expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases.
Ishimura N; Fukuda R; Fukumoto S
J Gastroenterol Hepatol; 1996 Aug; 11(8):712-7. PubMed ID: 8872766
[TBL] [Abstract][Full Text] [Related]
14. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
15. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.
García-Samaniego J; Soriano V; Castilla J; Bravo R; Moreno A; Carbó J; Iñiguez A; González J; Muñoz F
Am J Gastroenterol; 1997 Jul; 92(7):1130-4. PubMed ID: 9219784
[TBL] [Abstract][Full Text] [Related]
16. Critical role of CREBH-mediated induction of transforming growth factor β2 by hepatitis C virus infection in fibrogenic responses in hepatic stellate cells.
Chida T; Ito M; Nakashima K; Kanegae Y; Aoshima T; Takabayashi S; Kawata K; Nakagawa Y; Yamamoto M; Shimano H; Matsuura T; Kobayashi Y; Suda T; Suzuki T
Hepatology; 2017 Nov; 66(5):1430-1443. PubMed ID: 28621467
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.
Bedossa P; Poynard T; Mathurin P; Lemaigre G; Chaput JC
Gut; 1993; 34(2 Suppl):S146-7. PubMed ID: 8314486
[TBL] [Abstract][Full Text] [Related]
18. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
19. Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C.
Tanaka H; El-Karef A; Kaito M; Kinoshita N; Fujita N; Horiike S; Watanabe S; Yoshida T; Adachi Y
Liver Int; 2006 Apr; 26(3):311-8. PubMed ID: 16584393
[TBL] [Abstract][Full Text] [Related]
20. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
